½ÓÖÖÒÒ¸ÎÒßÃçºó¶à¾Ã¿ÉÒÔÓÐÉí£¿Õâ¸öÎÊÌâÐèÒª´ÓÁ½·½Ãæ»Ø¸²£ºÒ»ÊÇÓÐÉí¸¾Å®Äܲ»¿É½ÓÖÖÒÒ¸ÎÒßÃ磿ÒÒ¸ÎÒßÃç»á²»»áÓ°ÏìÌ¥¶ù£¿¶þÊÇΪʲôҪÇóÏÈ´òÒßÃçÔÙÓÐÉí£¿
ÓÐÉíʱ´úÊÇ¿ÉÒÔ½ÓÖÖÒÒ¸ÎÒßÃçµÄ£¬ÒÒ¸ÎÒßÃç²»»áÓ°ÏìÌ¥¶ù¡£ÓÐÉíʱ´úһЩ¼õ¶¾»îÒßÃçÊDz»¿É½ÓÖֵģ¬ÈçÂéÕîÒßÃç¡¢·çÕîÒßÃ硢ʢÐÐÐÔÈùÏÙÑ×ÒßÃçÒÔ¼°ËüÃǵÄÍŽáÒßÃçµÈ¡£¼õ¶¾»îÒßÃç¿ÉÒÔÔÚÈÑÉ︾ŮÌåÄÚ¸´ÖÆ£¬±£´æÌ¥¶ùѬȾ¡¢Á÷²ú»òÌ¥¶ù»ûÐεÄΣº¦¡£Ò»Ñùƽ³£À´Ëµ£¬Ãð»îÒßÃçºÍ»ùÒò¹¤³ÌÒßÃç¶ÔÓÐÉí¸¾Å®ÊÇÇå¾²µÄ¡£ÒÒ¸ÎÒßÃçÊôÓÚ»ùÒò¹¤³ÌÒßÃ磬Òò´Ë²»»áÓ°ÏìÓÐÉíºÍÌ¥¶ù¡£
ÔçÓÐÁÙ´²Ñо¿Ö¤ÊµÓÐÉí¸¾Å®½ÓÖÖÒÒ¸ÎÒßÃçÊÇÇå¾²µÄ¡£ÈÑÉ︾Ů½ÓÖÖÒÒ¸ÎÒßÃçºó£¬²»µ«¿ÉÒԺͷÇÈÑÉ︾ŮһÑù±¬·¢¿¹Ì壬»¹¿ÉÒÔ°Ñ¿¹ÌåÔËË͵½Ì¥¶ùÌåÄÚ£¬Ê¹Ì¥¶ù»ñµÃÏÈÌìÐÔÃâÒßÁ¦£¬ÇÒ¶ÔÌ¥¶ùºÍĸÇ×ÎÞÏÔ×Ų»Á¼Ó°Ï죬²»»áµ¼ÖÂÌ¥¶ùÒì³£[1-3]¡£ÔÚÃÀ¹ú£¬ÒÒ¸ÎÒßÃçûÓб»ÁÐÈëÈÑÉïʱ´úեȡʹÓõÄÒßÃçÃûµ¥¡£½¨ÒéËùÓÐÈÑÉ︾ŮÔÚ²úǰɸ²éÒÒÐ͸ÎÑ×£»¹ØÓÚÒÒ¸ÎÍâò¿¹Ô(HBsAg)ÒõÐÔµÄÔи¾£¬ÈôÊÇÊôÓÚÒҸβ¡¶¾Ñ¬È¾µÄ¸ßΣÈËȺ£¬½¨ÒéÔÚÔÐÆÚ½ÓÖÖÒÒ¸ÎÒßÃç[4, 5]¡£Òò´Ë£¬ÔÐÆÚ½ÓÖÖÒÒ¸ÎÒßÃçÊÇÇå¾²µÄ¡£ÈôÊÇÔÚ½ÓÖÖÒÒ¸ÎÒßÃçºóÒâÍâÓÐÉí£¬²»±ØÌ«¹ý¹ÜÓÇ£¬ÒÒ¸ÎÒßÃç²»»áÓ°ÏìÌ¥¶ù·¢Óý£¬²»±ØÖÐÖ¹ÈÑÉï¡£
¿ÉÊÇ£¬ÎÒ¹ú¼²¿ØÖÐÐÄÒªÇó²»ÒªÔÚÓÐÉíʱ½ÓÖÖÒÒ¸ÎÒßÃ磬ÒҸβ¡¶¾Ñ¬È¾µÄ¸ßΣÓýÁ举Ů(Åäż»òÐÔͬ°éΪÒҸβ¡¶¾Ñ¬È¾Õß)Ó¦¸ÃÏÈ´òÒßÃçÔÙÓÐÉí¡£ÕâÒ»·½ÃæÊÇÓÉÓÚÒҸβ¡¶¾¿ÉÒÔͨ¹ýÐÔ½Ó´¥Èö²¥£¬Å®ÐÔ½ÓÖÖ3ÕëÒÒ¸ÎÒßÃ籬·¢¿¹ÌåºóÔÙÓÐÉí£¬²»µ«¿ÉÒÔÓÐÓÃÔ¤·ÀÐÔ½Ó´¥Ê±Ñ¬È¾ÒҸβ¡¶¾£¬Ò²¿ÉÒÔ°ÑÌåÄڵĿ¹Ìå×ªÒÆ¸øÌ¥¶ù¡£ÁíÒ»·½Ã棬ֻ¹ÜÒÒ¸ÎÒßÃç¶ÔÈÑÉï¼°Ì¥¶ùÎÞÓ°Ï죬µ«ÔÐÆÚ½ÓÖÖÒßÃçºó£¬Ò»µ©·ºÆð×ÔÈ»Á÷²ú¡¢Ì¥¶ùÒì³£µÈµÄÇɺÏÖ¢£¬»áÈÃÒßÃç±³ÉÏ¡°ºÚ¹ø¡±£¬ÔÐǰ½ÓÖÖÒßÃç¿ÉÒÔ×èÖ¹ÕâЩûÓÐÐëÒªµÄƶÀ§¡£
²Î¿¼ÎÄÏ×£º
[1] Levy M, Koren G. Hepatitis B vaccine in pregnancy: maternal and fetal safety. Am J Perinatol. 1991. 8(3): 227-32.
[2] Ayoola EA, Johnson AO. Hepatitis B vaccine in pregnancy: immunogenicity, safety and transfer of antibodies to infants. Int J Gynaecol Obstet. 1987. 25(4): 297-301.
[3] Gupta I, Ratho RK. Immunogenicity and safety of two schedules of Hepatitis B vaccination during pregnancy. J Obstet Gynaecol Res. 2003. 29(2): 84-6.
[4] Stewart RD, Sheffield JS. Hepatitis B Vaccination in Pregnancy in the United States. Vaccines (Basel). 2013. 1(2): 167-73.
[5] Tran TT. Management of hepatitis B in pregnancy: weighing the options. Cleve Clin J Med. 2009. 76 Suppl 3: S25-9.


Ãö¹«Íø°²±¸ 35092602000113ºÅ